- Report
- June 2026
- 800 Pages
Global
From €2672EUR$3,000USD£2,285GBP
- Report
- August 2026
- 181 Pages
Global
From €3158EUR$3,545USD£2,700GBP
€3509EUR$3,939USD£3,000GBP
- Report
- August 2026
- 184 Pages
Global
From €3158EUR$3,545USD£2,700GBP
€3509EUR$3,939USD£3,000GBP
- Report
- August 2026
- 187 Pages
Global
From €3158EUR$3,545USD£2,700GBP
€3509EUR$3,939USD£3,000GBP
- Report
- September 2026
- 181 Pages
Global
From €5211EUR$5,850USD£4,455GBP
- Report
- September 2026
- 267 Pages
Global
From €5211EUR$5,850USD£4,455GBP
- Report
- September 2026
- 466 Pages
Global
From €5211EUR$5,850USD£4,455GBP
- Report
- September 2026
- 269 Pages
Global
From €5211EUR$5,850USD£4,455GBP
- Report
- September 2026
- 135 Pages
Global
From €5211EUR$5,850USD£4,455GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,420GBP
- Report
- April 2026
- 280 Pages
Global
From €4454EUR$5,000USD£3,808GBP
- Report
- May 2026
- 350 Pages
Global
From €4408EUR$4,949USD£3,769GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2484EUR$2,789USD£2,124GBP
- Report
- May 2026
- 150 Pages
Global
From €2484EUR$2,789USD£2,124GBP
- Report
- May 2026
- 350 Pages
Global
From €4408EUR$4,949USD£3,769GBP
- Report
- July 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,529GBP
€3697EUR$4,150USD£3,161GBP
- Report
- February 2026
- 170 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- November 2025
- 150 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- May 2026
- 130 Pages
Global
From €4320EUR$4,850USD£3,694GBP
- Report
- January 2020
- 300 Pages
Global
From €2939EUR$3,300USD£2,513GBP

The Cancer Drug Development market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs to treat cancer, a disease that affects millions of people worldwide. This market includes the research and development of new drugs, as well as the testing and approval of existing drugs for use in cancer treatment. Companies in this market must adhere to strict regulations and guidelines set by regulatory bodies such as the US Food and Drug Administration (FDA).
The Cancer Drug Development market is highly competitive, with many companies vying for a share of the market. Companies in this market include large pharmaceutical companies, biotechnology companies, and smaller start-ups. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more